Elon Musk sold around $4 billion worth of Tesla shares

Elon Musk sold around billion worth of Tesla shares

Elon Musk, founder of SpaceX and chief executive officer of Tesla, waves while arriving to a discussion at the Satellite 2020 Conference in Washington, D.C., on Monday, March 9, 2020.

Andrew Harrer | Bloomberg | Getty Images

Elon Musk sold roughly $4 billion worth of Tesla shares, according to filings with the Securities and Exchange Commission.

In a flurry of trades executed Tuesday and Wednesday, the Tesla and SpaceX CEO offloaded about 4.4 million shares of his electric vehicle company.

The bulk of the CEO’s sales were made on Tuesday, the filings showed. Tesla shares fell 12% that day, but edged higher on Wednesday by less than one percentage point.

As the filings became public Thursday evening, Musk wrote on Twitter, “No further TSLA sales planned after today.” He made the remark in response to an account that heavily promotes Tesla stock, products and Musk on the social network.

This is breaking news. Please check back for updates.

Source

World

Fed officials split on where interest rates should go, minutes say

February 18, 2026

Divided Federal Reserve officials at their January meeting indicated that further interest rate cuts should be paused for now but could resume later in the year only if inflation cooperates. While the decision to hold the central bank’s benchmark rate steady mostly was met with approval, the path ahead appeared less certain, with members conflicted […]

World

Microsoft’s Brad Smith says U.S. tech should ‘worry a little’ about Chinese firms’ government subsidies

February 18, 2026

Microsoft President Brad Smith speaks at a press conference at the Representation of the State of North Rhine-Westphalia about future visions for the development and application of artificial intelligence in education in NRW in Berlin on June 4, 2025. Soeren Stache | Picture Alliance | Getty Images American tech companies should “worry a little bit” […]

World

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

February 18, 2026

A researcher works in the lab at the Moderna headquarters in Cambridge, Massachusetts, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna said on Wednesday the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing the agency’s earlier decision to refuse to accept the application in a move […]